Pure honey UK is most commonly used for burns, wound healing, swelling (inflammation) and sores inside the mouth (oral mucositis), and cough. It is also used for many other conditions but there is no good scientific evidence to support most of these uses.
https://wild-about-honey.blogspot.com/2021/06/benefits-of-honey-in-our-daily-life.html
(Albany, US) DelveInsight has launched a new report on Oral Mucositis Market Insights, Epidemiology and Market Forecast-2030DelveInsight’s “Oral Mucositis (OM) - Market Insights, Epidemiology and Market Forecast - 2030” report provides an overview of the disease and market size of Oral Mucositis for the 7MM major pharmaceutical markets, i.e., the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
This report covers the various treatment practices, and Oral Mucositis forecasted epidemiology from 2020 to 2030, segmented by the 7 major markets.Some of the key facts of the Report:In 2017, US had the maximum number of incident cases of the total incident cases followed by Japan.Grade 3 or 4 Oral Mucositis occurs in around 85% of patients receiving high-dose radiotherapy.In 2017, the incident population of Oral Mucositis in the United States was 1,956,351.
)Oral Mucositis market report provides insights on the current and emerging therapies.
Oral Mucositis market report offers a global historical and forecasted market covering drug outreach in 7 MM.Oral Mucositis market report provides an edge that will help in developing business strategies by understanding trends shaping and driving the Malignant Mesothelioma market.Request for Sample Pages : https://www.delveinsight.com/sample-request/oral-mucositis-om-market“According to Delveinsight, females appear to be more likely than males to develop Oral mucositis.”View Report: https://www.delveinsight.com/report-store/oral-mucositis-om-marketOral Mucositis (OM) is the most common, debilitating complication of cancer chemotherapy and radiotherapy.
It is characterized by inflammation and ulceration in the oral cavity caused by the chemotherapeutic drug substances and radiotherapy used in cancer treatment.
The early symptoms include erythema and light discoloration of the mucosa.
COVID-19 Impact Analysis on Chemotherapy-Induced Oral Mucositis Market report published by Value Market Research provides a detailed market analysis comprising market size, share, value, growth and trends for the period 2020-2027.
Moreover, this market report also covers regional and country markets in detail.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the chemotherapy-induced oral mucositis market include Izun Pharmaceuticals, Aurora Bioscience, Camurus AB, Prothex Inc., Swedish Orphan Biovitrum AB, Soleva Pharma, Access Pharmaceutical Inc., NeoMedLight, INNOVATION Pharma, Monopar TherapeuticsAccess Pharmaceutical Inc., and Swedish Orphan Biovitrum AB.
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Chemotherapy-Induced Oral Mucositis Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/chemotherapy-induced-oral-mucositis-market/download-sampleMarket DynamicsThe increase in usage of chemotherapeutic agents due to the increasing incidence of cancers is the major factor driving the chemotherapy-induced oral mucositis market.
The rise in the number of patients receiving chemotherapy each year leads to a high need for the treatment of oral mucositis.
The increased elderly population, as they are more susceptible to cancer, is leading to high demand for the treatment of chemotherapy-induced oral mucositis.